Literature DB >> 7685401

A model system for nonhomologous recombination between retroviral and cellular RNA.

A M Hajjar1, M L Linial.   

Abstract

A current model for the generation of transforming retroviruses proposes that read-through RNAs, containing both viral and cellular sequences, are copackaged with viral genomic RNA. It is, however, possible that a cellular mRNA is occasionally encapsidated into a retroviral particle, even though viral packaging sequences are absent. We have generated recombinant proviruses following copackaging of an avian leukosis viral genomic RNA and a neo-containing RNA completely devoid of retroviral sequences. In these studies, we used the packaging cell line SE21Q1b, which has the unique ability to randomly package cellular mRNA into retroviral particles. We describe 10 recombinants obtained following copackaging of nonhomologous RNAs. Our data show that recombination is not occurring at the DNA level in the parental SE21Q1b cells but is occurring at the RNA level, during reverse transcription. These data further suggest that reverse transcriptase can preferentially jump between templates at short stretches of homology in otherwise unrelated RNAs. We conclude that retroviral sequences are not required for packaged mRNA to be reverse transcribed and to be included in integrated proviruses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685401      PMCID: PMC237749     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Retroviral recombination during reverse transcription.

Authors:  D W Goodrich; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Transduction of cellular neo mRNA by retrovirus-mediated recombination.

Authors:  H Stuhlmann; M Dieckmann; P Berg
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination.

Authors:  W S Hu; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Rearrangements in unintegrated retroviral DNA are complex and are the result of multiple genetic determinants.

Authors:  J C Olsen; C Bova-Hill; D P Grandgenett; T P Quinn; J P Manfredi; R Swanstrom
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

5.  Unusual features of integrated cDNAs generated by infection with genome-free retroviruses.

Authors:  K L Levine; B Steiner; K Johnson; R Aronoff; T J Quinton; M L Linial
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors.

Authors:  S H Hughes; J J Greenhouse; C J Petropoulos; P Sutrave
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

8.  Evidence that retroviral transduction is mediated by DNA not by RNA.

Authors:  D W Goodrich; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Retroviral transduction of oncogenic sequences involves viral DNA instead of RNA.

Authors:  D W Goodrich; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Conserved arrangement of nested genes at the Drosophila Gart locus.

Authors:  S Henikoff; M K Eghtedarzadeh
Journal:  Genetics       Date:  1987-12       Impact factor: 4.562

View more
  24 in total

1.  Evolution and horizontal transfer of dUTPase-encoding genes in viruses and their hosts.

Authors:  A M Baldo; M A McClure
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.

Authors:  C R Logg; A Logg; C K Tai; P M Cannon; N Kasahara
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses.

Authors:  Shainn-Wei Wang; Kristin Noonan; Anna Aldovini
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

4.  Acutely transforming retrovirus expressing Nras generated from HT-1080 fibrosarcoma cells infected with the human retrovirus XMRV.

Authors:  Michael J Metzger; A Dusty Miller
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

5.  Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transduction.

Authors:  Yutaka Takebe; Alice Telesnitsky
Journal:  Virology       Date:  2006-06-14       Impact factor: 3.616

6.  Effects of identity minimization on Moloney murine leukemia virus template recognition and frequent tertiary template-directed insertions during nonhomologous recombination.

Authors:  Nisha K Duggal; Leslie Goo; Steven R King; Alice Telesnitsky
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

7.  Premature strand transfer by the HIV-1 reverse transcriptase during strong-stop DNA synthesis.

Authors:  B Klaver; B Berkhout
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

8.  Modification of retroviral RNA by double-stranded RNA adenosine deaminase.

Authors:  A M Hajjar; M L Linial
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

9.  Homologous and nonhomologous retroviral recombinations are both involved in the transfer by infectious particles of defective avian leukosis virus-derived transcomplementing genomes.

Authors:  A Girod; A Drynda; F L Cosset; G Verdier; C Ronfort
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

10.  The recombination rate is not increased when retroviral RNA is missing an encapsidation sequence.

Authors:  J Zhang; H M Temin
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.